Prosecution Insights
Prosecution Insights
8 pending office actions • 6 clients • 8 examiners • 7 art units • 0 of 8 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (25%) |
| §112 only | 1 (12%) |
| Multi-statute (no §101) | 5 (62%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MACCHIAROLO, LEAH SIMONE | 1 | 62.2% | +31.8% |
| BERGIN, JAMES S | 1 | 79.3% | +10.1% |
| NGUYEN, JOHN P | 1 | 44.2% | +41.4% |
| KAMM, JUDITH MARIE | 1 | 45.8% | +59.4% |
| LIPPERT, JOHN WILLIAM | 1 | 56.6% | +41.3% |
| COUGHLIN, DANIEL F | 1 | 39.2% | +19.5% |
| BRAUN, MADELINE E | 1 | 67.9% | +25.4% |
| DRAPER, LESLIE A ROYDS | 1 | 27.3% | +43.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17274726 | Use of CFTR Modulators For Treating Cerebrovascular Conditions | DRAPER, LESLIE A ROYDS | 66d overdue |
| 18001582 | Pharmaceutical Compositions Containing Enterokine Releasing Substances In Multiple Dosage Forms In Combination With Gelling Agents | NGUYEN, JOHN P | 9d |
| 19226068 | Track Lighting System With Integrated DMX Control Signal Splitter, Isolator And/Or Booster | MACCHIAROLO, LEAH SIMONE | — |
| 18490901 | Progressive Loading Press for Ammunition | BERGIN, JAMES S | — |
| 17615431 | Additive Method For 3D Printing Active Ingredient-Containing Objects | KAMM, JUDITH MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17274726 | Use of CFTR Modulators For Treating Cerebrovascular Conditions | DRAPER, LESLIE A ROYDS | 66d overdue |
| 18001582 | Pharmaceutical Compositions Containing Enterokine Releasing Substances In Multiple Dosage Forms In Combination With Gelling Agents | NGUYEN, JOHN P | 9d |
| 17615559 | Polyvalent Dosage Forms and Method For Their Production | COUGHLIN, DANIEL F | 40d |
| 19226068 | Track Lighting System With Integrated DMX Control Signal Splitter, Isolator And/Or Booster | MACCHIAROLO, LEAH SIMONE | — |
| 18490901 | Progressive Loading Press for Ammunition | BERGIN, JAMES S | — |
| 17615431 | Additive Method For 3D Printing Active Ingredient-Containing Objects | KAMM, JUDITH MARIE | — |
| 17615450 | Pharmaceutical Dosage Forms and Method For Their Production | LIPPERT, JOHN WILLIAM | — |
| 17604718 | Oxazole And Oxadiazole Derivatives Useful As Agonists Of Free Fatty Acid Receptor 1 | BRAUN, MADELINE E | — |
| Client (Assignee) | Pending OAs |
|---|---|
| DiHeSys Digital Health Systems | 3 |
| Lighting Services, Inc. | 1 |
| Lyman Products Corporation | 1 |
| APHAIA IP AG | 1 |
| Halo Therapeutics Ltd. | 1 |
| Qanatpharma AG | 1 |
| Art Unit | Apps |
|---|---|
| 1619 | 2 |
| 2875 | 1 |
| 3641 | 1 |
| 1611 | 1 |
| 1615 | 1 |
| 1624 | 1 |
| 1629 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19226068 | Track Lighting System With Integrated DMX Control Signal Splitter, Isolator And/Or Booster | Lighting Services, Inc. | MACCHIAROLO, LEAH SIMONE | 2875 | §102§103 | Non-Final OA | — | Pending | Jun 02, 2025 |
| 18490901 | Progressive Loading Press for Ammunition | Lyman Products Corporation | BERGIN, JAMES S | 3641 | §102§103 | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18001582 | Pharmaceutical Compositions Containing Enterokine Releasing Substances In Multiple Dosage Forms In Combination With Gelling Agents | Aphaia Ip AG | NGUYEN, JOHN P | 1619 | §103§112 | Non-Final OA | 9d | Pending | Dec 12, 2022 |
| 17615431 | Additive Method For 3D Printing Active Ingredient-Containing Objects | Dihesys Digital Health Systems GmbH | KAMM, JUDITH MARIE | 1611 | §103§112 | Non-Final OA | — | Pending | Mar 23, 2022 |
| 17615450 | Pharmaceutical Dosage Forms and Method For Their Production | Dihesys Digital Health Systems GmbH | LIPPERT, JOHN WILLIAM | 1615 | §103 | Non-Final OA | — | Pending | Nov 30, 2021 |
| 17615559 | Polyvalent Dosage Forms and Method For Their Production | Dihesys Digital Health Systems GmbH | COUGHLIN, DANIEL F | 1619 | §103 | Non-Final OA | 40d | Pending | Nov 30, 2021 |
| 17604718 | Oxazole And Oxadiazole Derivatives Useful As Agonists Of Free Fatty Acid Receptor 1 | Halo Therapeutics Ltd. | BRAUN, MADELINE E | 1624 | §112Other | Non-Final OA | — | Pending | Oct 18, 2021 |
| 17274726 | Use of CFTR Modulators For Treating Cerebrovascular Conditions | Qanatpharma AG | DRAPER, LESLIE A ROYDS | 1629 | §102§103 | Final Rejection | 66d overdue | Pending | Mar 09, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial